GB Patent

GB2448193A — Nasal delivery device

Assigned to Optinose AS · Expires 2008-10-08 · 18y expired

What this patent protects

A nasal delivery device for and method of delivering substance to a nasal cavity of a subject, the delivery device comprising: a nosepiece 17 for fitting to a nostril of a subject, wherein the nosepiece comprises a tip element 25 which includes a delivery aperture 26 from which s…

USPTO Abstract

A nasal delivery device for and method of delivering substance to a nasal cavity of a subject, the delivery device comprising: a nosepiece 17 for fitting to a nostril of a subject, wherein the nosepiece comprises a tip element 25 which includes a delivery aperture 26 from which substance is in use delivered into the nasal cavity, and the tip element 25 is at least in part tapered such as to be inclined to a longitudinal axis of the nosepiece 17, with the delivery aperture 26 extending both laterally across the tip element 25 and along a longitudinal extent of the tip element; a nozzle 35 through which substance is in use delivered, preferably substantially axially to a longitudinal axis of the nosepiece 17, to the respective nasal cavity; and a delivery unit for delivering substance through the nozzle 35 of the nosepiece. The nosepiece 17 may also include a nose gripping member 255.

Drugs covered by this patent

Patent Metadata

Patent number
GB2448193A
Jurisdiction
GB
Classification
Expires
2008-10-08
Drug substance claim
No
Drug product claim
No
Assignee
Optinose AS
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.